SpecificiT Pharma Alternatives & Competitors
12 companies similar to SpecificiT Pharma — Pioneering personalized cancer therapies with a novel approach using Minor Histo...
Companies similar to SpecificiT Pharma
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
Leucid Bio
Thinking laterally about CAR-T. Develops Autologous and Allogeneic cell and gene Therapies...
London, United Kingdom
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
Rival Readout
Competing with SpecificiT Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImmuneBridge
Bridging research and translation for a healthy future.
San Francisco, United Sta...
Rebirthel Co.,Ltd.
An independent biocompany, developing cellular immunotherapies for cancer, based on Kyoto.
Kyoto, Japan
Minerva Biotechnologies
We see the future first
Waltham, United States
OncoPep, Inc.
To develop and commercialize targeted immuno-therapeutics which prevent the progression of...
Boston, United States
Gritstone bio
A lean biotech company aiming to develop revolutionary immune-based treatment for various...
Emeryville, United States
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
NEOGAP Therapeutics AB
Science for cure.
Stockholm, Sweden
About SpecificiT Pharma
SpecificiT Pharma is a pioneering biopharmaceutical company founded in 2016 with a focus on creating innovative personalized cancer immunotherapies. The company's mission is to target hematological cancers using a novel approach that involves the utilization of Minor Histocompatibility Antigens (MiHAs), thereby enablin...
Personalized Medicine, Immunotherapy, Cancer Treatment, Cell Therapy, Biopharmaceuticals, Innovative Therapies, Hematological Cancers, CAR-T Therapy, MiHAs, Oncology, Minor Histocompatibility Antigens, T-cell Therapy
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around SpecificiT Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at SpecificiT Pharma on 26 Jul 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
